av/advanced-enzymes--big.svg

COM:ADVANCEDENZYMES

Advanced Enzymes

  • Stock

Last Close

370.90

22/11 10:00

Market Cap

42.66B

Beta: -

Volume Today

116.65K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
472.60M
-
512.84M
8.51%
565.63M
10.29%
644.86M
14.01%
720.26M
11.69%
762.36M
5.84%
784.64M
2.92%
869.55M
10.82%
1.07B
23.51%
1.22B
14.02%
average payables
137.41M
-
110.86M
19.32%
120.13M
8.35%
116.73M
2.82%
142.41M
22.00%
135.79M
4.65%
96.64M
28.83%
124.30M
28.62%
165.57M
33.21%
210.59M
27.19%
average receivables
424.32M
-
432.38M
1.90%
490.92M
13.54%
608.25M
23.90%
727.33M
19.58%
698.52M
3.96%
758.15M
8.54%
959.67M
26.58%
1.05B
9.59%
1.03B
2.21%
book value per share
15.38
-
19.47
26.61%
25.55
31.21%
41.57
62.69%
50.08
20.48%
60.80
21.40%
75.19
23.66%
86.90
15.58%
97.39
12.07%
110.48
13.45%
capex per share
-0.88
-
-1.16
31.39%
-0.90
22.07%
-1.07
18.41%
-0.98
8.19%
-1.11
13.07%
-4.54
308.85%
-1.75
61.35%
-2.52
43.80%
-3.42
35.50%
capex to depreciation
-0.96
-
-1.40
45.46%
-1.13
19.42%
-0.97
13.99%
-0.60
38.22%
-0.59
2.01%
-1.96
234.98%
-0.69
64.93%
-0.81
16.87%
-1.09
35.33%
capex to operating cash flow
-0.17
-
-0.23
35.88%
-0.10
57.17%
-0.11
9.67%
-0.09
14.30%
-0.10
2.01%
-0.36
273.14%
-0.12
66.56%
-0.23
91.68%
-0.27
18.06%
capex to revenue
-0.04
-
-0.06
26.91%
-0.03
40.86%
-0.04
6.78%
-0.03
21.21%
-0.03
5.01%
-0.11
286.88%
-0.04
65.89%
-0.05
36.16%
-0.07
32.57%
cash per share
-1.32
-
-1.07
18.53%
0.76
170.72%
0.71
6.39%
5.62
689.65%
12.11
115.68%
18.59
53.47%
28.35
52.50%
33.44
17.93%
43.46
29.98%
days of inventory on hand
327.14
-
346.63
5.96%
323.40
6.70%
330.36
2.15%
309.73
6.25%
344.80
11.32%
335.04
2.83%
324.51
3.14%
369.55
13.88%
343.36
7.09%
days payables outstanding
68.69
-
76.97
12.06%
65.96
14.31%
53.11
19.47%
71.61
34.83%
43.43
39.36%
40.37
7.05%
52.60
30.31%
54.70
3.99%
67.07
22.63%
days sales outstanding
66.99
-
77.40
15.53%
63.71
17.68%
78.03
22.46%
70.47
9.68%
56.63
19.65%
71.77
26.75%
76.66
6.81%
72.61
5.28%
67.82
6.60%
debt to assets
0.41
-
0.28
32.63%
0.22
18.66%
0.09
58.35%
0.09
4.14%
0.04
51.92%
0.03
21.01%
0.02
29.76%
0.03
14.36%
0.02
14.01%
debt to equity
1.00
-
0.54
45.50%
0.36
32.84%
0.12
67.79%
0.12
0.12%
0.05
56.10%
0.04
22.95%
0.03
28.44%
0.03
12.14%
0.03
14.98%
dividend yield
0.00
-
0.00
56.36%
0.00
51.57%
0.00
2.37%
0.00
206.41%
0.00
25.31%
0.01
70.39%
0.00
68.68%
0.00
81.58%
0.00
28.58%
earnings yield
0.01
-
0.02
158.30%
0.03
48.81%
0.02
32.79%
0.04
84.60%
0.05
45.99%
0.08
51.64%
0.04
53.30%
0.04
0.05%
0.04
7.41%
enterprise value
27.29B
-
26.75B
1.96%
26.39B
1.35%
46.06B
74.50%
24.58B
46.62%
20.85B
15.20%
15.42B
26.03%
36.89B
139.21%
29.21B
20.82%
25.31B
13.36%
enterprise value over ebitda
35.65
-
29.05
18.52%
19.05
34.43%
29.91
57.01%
15.01
49.81%
10.97
26.89%
7.39
32.70%
15.33
107.60%
14.07
8.25%
13.91
1.11%
ev to operating cash flow
49.11
-
49.79
1.39%
27.00
45.78%
42.90
58.89%
21.20
50.59%
16.21
23.50%
10.94
32.51%
22.64
106.91%
23.88
5.47%
18.03
24.51%
ev to sales
12.72
-
12.05
5.31%
9.02
25.13%
13.95
54.70%
6.34
54.58%
4.99
21.25%
3.49
30.02%
7.37
111.06%
5.52
25.08%
4.68
15.24%
free cash flow per share
4.22
-
3.78
10.55%
8.08
113.85%
8.63
6.81%
9.41
9.02%
10.41
10.61%
8.08
22.34%
12.83
58.76%
8.42
34.38%
9.14
8.56%
free cash flow yield
0.02
-
0.02
10.55%
0.03
113.85%
0.02
38.90%
0.04
104.30%
0.06
30.95%
0.06
1.18%
0.04
34.42%
0.03
19.76%
0.04
32.00%
graham net net
-17.90
-
-13.74
23.27%
-8.29
39.63%
-0.81
90.19%
0.60
173.75%
10.39
1,632.12%
18.05
73.72%
28.70
58.97%
34.52
20.29%
43.43
25.80%
graham number
25.05
-
45.30
80.84%
63.30
39.74%
87.52
38.26%
95.35
8.94%
116.66
22.35%
139.96
19.97%
159.98
14.31%
153.11
4.29%
153.27
0.10%
income quality
1.95
-
0.72
63.22%
0.83
15.16%
0.79
4.97%
0.83
6.18%
0.79
4.88%
0.79
0.92%
0.77
1.55%
0.71
7.67%
1.00
39.85%
intangibles to total assets
0.42
-
0.42
0.19%
0.39
7.00%
0.44
13.71%
0.45
2.22%
0.42
7.92%
0.37
12.42%
0.32
12.91%
0.29
10.44%
0.27
6.08%
interest coverage
7.90
-
10.36
31.14%
19.66
89.80%
35.89
82.60%
31.33
12.72%
42.69
36.26%
70.88
66.06%
133.11
87.78%
96.12
27.79%
60.67
36.88%
interest debt per share
16.13
-
11.30
29.97%
9.93
12.15%
5.23
47.28%
6.31
20.57%
3.48
44.79%
3.22
7.54%
2.62
18.80%
3.27
24.96%
3.21
1.67%
inventory turnover
1.12
-
1.05
5.62%
1.13
7.18%
1.10
2.11%
1.18
6.66%
1.06
10.17%
1.09
2.91%
1.12
3.24%
0.99
12.19%
1.06
7.63%
invested capital
1.00
-
0.54
45.50%
0.36
32.84%
0.12
67.79%
0.12
0.12%
0.05
56.10%
0.04
22.95%
0.03
28.44%
0.03
12.14%
0.03
14.98%
market cap
25.65B
-
25.65B
0%
25.64B
0.02%
45.59B
77.81%
24.54B
46.18%
20.73B
15.52%
15.91B
23.23%
38.53B
142.12%
31.53B
18.16%
25.93B
17.75%
net current asset value
-1.43B
-
-953.61M
33.31%
-273.59M
71.31%
429.11M
256.84%
655.61M
52.78%
1.76B
168.11%
2.64B
50.43%
3.94B
49.07%
4.73B
20.03%
5.83B
23.30%
net debt to ebitda
2.14
-
1.20
43.93%
0.54
54.94%
0.30
44.66%
0.03
90.67%
0.06
125.17%
-0.24
474.76%
-0.68
189.33%
-1.12
64.07%
-0.35
69.13%
net income per share
1.81
-
4.68
158.30%
6.97
48.81%
8.19
17.50%
8.07
1.49%
9.95
23.31%
11.58
16.39%
13.09
13.05%
10.70
18.26%
9.45
11.67%
operating cash flow per share
5.10
-
4.94
3.30%
8.98
81.96%
9.70
7.97%
10.39
7.12%
11.52
10.84%
12.62
9.57%
14.58
15.58%
10.94
24.98%
12.56
14.77%
payables turnover
5.31
-
4.74
10.76%
5.53
16.71%
6.87
24.18%
5.10
25.83%
8.41
64.91%
9.04
7.58%
6.94
23.26%
6.67
3.83%
5.44
18.45%
receivables turnover
5.45
-
4.72
13.44%
5.73
21.48%
4.68
18.34%
5.18
10.72%
6.45
24.46%
5.09
21.10%
4.76
6.38%
5.03
5.58%
5.38
7.07%
research and ddevelopement to revenue
0.00
-
0.00
-
0.00
20.38%
0.00
9.63%
0.00
18.84%
0.00
2.67%
0.00
22.33%
return on tangible assets
0.08
-
0.21
151.84%
0.28
30.71%
0.28
2.40%
0.23
20.30%
0.24
4.36%
0.21
11.43%
0.19
10.67%
0.13
29.09%
0.10
23.12%
revenue per share
19.71
-
20.41
3.54%
26.89
31.78%
29.82
10.90%
34.75
16.53%
37.42
7.67%
39.54
5.68%
44.80
13.31%
47.32
5.61%
48.36
2.21%
roe
0.12
-
0.24
104.02%
0.27
13.41%
0.20
27.78%
0.16
18.23%
0.16
1.57%
0.15
5.88%
0.15
2.19%
0.11
27.07%
0.09
22.14%
roic
0.16
-
0.17
12.05%
0.22
28.50%
0.18
17.94%
0.16
13.49%
0.17
3.71%
0.15
7.17%
0.15
1.05%
0.11
28.22%
0.08
22.59%
sales general and administrative to revenue
0.05
-
0.04
12.20%
0.03
41.23%
0.03
9.86%
0.04
26.13%
0.03
9.43%
0.03
14.49%
0.03
15.85%
0.04
23.86%
0.04
3.06%
shareholders equity per share
15.38
-
19.47
26.61%
25.55
31.21%
41.57
62.69%
50.08
20.48%
60.80
21.40%
75.19
23.66%
86.90
15.58%
97.39
12.07%
110.48
13.45%
stock based compensation to revenue
0.00
-
0.01
583.58%
0.00
46.44%
0.00
40.54%
0.00
62.14%
tangible asset value
60K
-
415.67M
692,683.33%
1.07B
158.09%
2.16B
101.49%
2.49B
15.26%
3.65B
46.64%
5.09B
39.25%
6.63B
30.28%
7.78B
17.38%
9.02B
15.99%
tangible book value per share
0.00
-
3.82
692,683.33%
9.86
158.15%
19.53
98.10%
22.32
14.30%
32.73
46.62%
45.56
39.22%
59.34
30.25%
69.60
17.29%
80.73
15.98%
working capital
-405.93M
-
-265.91M
34.49%
289.56M
208.89%
817M
182.15%
1.13B
37.87%
2.17B
92.61%
3.16B
45.67%
4.49B
41.92%
5.40B
20.38%
6.43B
19.18%

All numbers in (except ratios and percentages)